Membrane tumor necrosis factor-α (TNF-α) expressed on HTLV-I-infected T cells mediates a costimulatory signal for B cell activation - Characterization of membrane TNF-α

Masanori Higuchi, Kohei Nagasawa, Takahiko Horiuchi, Masahiro Oike, Yushi Ito, Masaki Yasukawa, Yoshiyuki Niho

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

The 26-kDa membrane tumor necrosis factor-α (TNF-α) expressed on activated CD4+ T cells is a novel candidate for the functional membrane molecule in T-B cell interactions. We found that normal human T cells, when infected with human T cell lymphotropic virus type I (HTLV-I) in vitro, were induced to express the 26-kDa membrane TNF-α. The infected T cells, through this molecule, activated autologous B cells to produce immunoglobulin (Ig)M in a contact-dependent manner, which was partially inhibited by anti-TNF-α antibody (Ab). IgG synthesis was not stimulated, however, probably because of lack of CD40 ligand expression on the infected T cells. Anti-TNF-α Ab treatment stimulated the secretion of interleukin (IL)-2 and interferon gamma (IFN-γ) in the infected T cells. These effects were not induced by anti-TNF receptor Ab treatment. Anti-TNF-α Ab also induced the elevation of intracellular calcium concentration in the infected T cells. These results suggest that T cells expressing membrane TNF-α can be directly stimulated through this molecule. Thus, it is suggested that the 26-kDa membrane TNF-α on HTLV-I-infected T cells plays a role in polyclonal B cell activation and may be involved in the pathogenesis of some HTLV-I-associated diseases. Additionally, our results suggest a novel mechanism by which cytokine production can be modulated in these T cells through membrane TNF-α on their surface.

Original languageEnglish
Pages (from-to)133-140
Number of pages8
JournalClinical Immunology and Immunopathology
Volume82
Issue number2
DOIs
Publication statusPublished - Jan 1 1997

Fingerprint

B-Lymphocytes
Tumor Necrosis Factor-alpha
Viruses
T-Lymphocytes
Membranes
Antibodies
Cell Membrane
CD40 Ligand
Tumor Necrosis Factor Receptors
Cell Communication
Interferon-gamma
Interleukin-2
Immunoglobulin M
Immunoglobulin G
Cytokines
Calcium

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Pathology and Forensic Medicine
  • Immunology

Cite this

Membrane tumor necrosis factor-α (TNF-α) expressed on HTLV-I-infected T cells mediates a costimulatory signal for B cell activation - Characterization of membrane TNF-α. / Higuchi, Masanori; Nagasawa, Kohei; Horiuchi, Takahiko; Oike, Masahiro; Ito, Yushi; Yasukawa, Masaki; Niho, Yoshiyuki.

In: Clinical Immunology and Immunopathology, Vol. 82, No. 2, 01.01.1997, p. 133-140.

Research output: Contribution to journalArticle

@article{555e6e4a873649868f36c3993e7ce989,
title = "Membrane tumor necrosis factor-α (TNF-α) expressed on HTLV-I-infected T cells mediates a costimulatory signal for B cell activation - Characterization of membrane TNF-α",
abstract = "The 26-kDa membrane tumor necrosis factor-α (TNF-α) expressed on activated CD4+ T cells is a novel candidate for the functional membrane molecule in T-B cell interactions. We found that normal human T cells, when infected with human T cell lymphotropic virus type I (HTLV-I) in vitro, were induced to express the 26-kDa membrane TNF-α. The infected T cells, through this molecule, activated autologous B cells to produce immunoglobulin (Ig)M in a contact-dependent manner, which was partially inhibited by anti-TNF-α antibody (Ab). IgG synthesis was not stimulated, however, probably because of lack of CD40 ligand expression on the infected T cells. Anti-TNF-α Ab treatment stimulated the secretion of interleukin (IL)-2 and interferon gamma (IFN-γ) in the infected T cells. These effects were not induced by anti-TNF receptor Ab treatment. Anti-TNF-α Ab also induced the elevation of intracellular calcium concentration in the infected T cells. These results suggest that T cells expressing membrane TNF-α can be directly stimulated through this molecule. Thus, it is suggested that the 26-kDa membrane TNF-α on HTLV-I-infected T cells plays a role in polyclonal B cell activation and may be involved in the pathogenesis of some HTLV-I-associated diseases. Additionally, our results suggest a novel mechanism by which cytokine production can be modulated in these T cells through membrane TNF-α on their surface.",
author = "Masanori Higuchi and Kohei Nagasawa and Takahiko Horiuchi and Masahiro Oike and Yushi Ito and Masaki Yasukawa and Yoshiyuki Niho",
year = "1997",
month = "1",
day = "1",
doi = "10.1006/clin.1996.4291",
language = "English",
volume = "82",
pages = "133--140",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Membrane tumor necrosis factor-α (TNF-α) expressed on HTLV-I-infected T cells mediates a costimulatory signal for B cell activation - Characterization of membrane TNF-α

AU - Higuchi, Masanori

AU - Nagasawa, Kohei

AU - Horiuchi, Takahiko

AU - Oike, Masahiro

AU - Ito, Yushi

AU - Yasukawa, Masaki

AU - Niho, Yoshiyuki

PY - 1997/1/1

Y1 - 1997/1/1

N2 - The 26-kDa membrane tumor necrosis factor-α (TNF-α) expressed on activated CD4+ T cells is a novel candidate for the functional membrane molecule in T-B cell interactions. We found that normal human T cells, when infected with human T cell lymphotropic virus type I (HTLV-I) in vitro, were induced to express the 26-kDa membrane TNF-α. The infected T cells, through this molecule, activated autologous B cells to produce immunoglobulin (Ig)M in a contact-dependent manner, which was partially inhibited by anti-TNF-α antibody (Ab). IgG synthesis was not stimulated, however, probably because of lack of CD40 ligand expression on the infected T cells. Anti-TNF-α Ab treatment stimulated the secretion of interleukin (IL)-2 and interferon gamma (IFN-γ) in the infected T cells. These effects were not induced by anti-TNF receptor Ab treatment. Anti-TNF-α Ab also induced the elevation of intracellular calcium concentration in the infected T cells. These results suggest that T cells expressing membrane TNF-α can be directly stimulated through this molecule. Thus, it is suggested that the 26-kDa membrane TNF-α on HTLV-I-infected T cells plays a role in polyclonal B cell activation and may be involved in the pathogenesis of some HTLV-I-associated diseases. Additionally, our results suggest a novel mechanism by which cytokine production can be modulated in these T cells through membrane TNF-α on their surface.

AB - The 26-kDa membrane tumor necrosis factor-α (TNF-α) expressed on activated CD4+ T cells is a novel candidate for the functional membrane molecule in T-B cell interactions. We found that normal human T cells, when infected with human T cell lymphotropic virus type I (HTLV-I) in vitro, were induced to express the 26-kDa membrane TNF-α. The infected T cells, through this molecule, activated autologous B cells to produce immunoglobulin (Ig)M in a contact-dependent manner, which was partially inhibited by anti-TNF-α antibody (Ab). IgG synthesis was not stimulated, however, probably because of lack of CD40 ligand expression on the infected T cells. Anti-TNF-α Ab treatment stimulated the secretion of interleukin (IL)-2 and interferon gamma (IFN-γ) in the infected T cells. These effects were not induced by anti-TNF receptor Ab treatment. Anti-TNF-α Ab also induced the elevation of intracellular calcium concentration in the infected T cells. These results suggest that T cells expressing membrane TNF-α can be directly stimulated through this molecule. Thus, it is suggested that the 26-kDa membrane TNF-α on HTLV-I-infected T cells plays a role in polyclonal B cell activation and may be involved in the pathogenesis of some HTLV-I-associated diseases. Additionally, our results suggest a novel mechanism by which cytokine production can be modulated in these T cells through membrane TNF-α on their surface.

UR - http://www.scopus.com/inward/record.url?scp=0031081260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031081260&partnerID=8YFLogxK

U2 - 10.1006/clin.1996.4291

DO - 10.1006/clin.1996.4291

M3 - Article

VL - 82

SP - 133

EP - 140

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 2

ER -